3 Questions: Jeffrey Harris on why we still don't have an HIV vaccine
Wednesday, November 4, 2009 - 17:35
in Health & Medicine
While many vaccines used around the world today are produced for profit by commercial firms, the private sector accounts for a tiny fraction of the funding for an HIV vaccine: 4 percent in 2008, down from 9 percent in 2007, according to Jeffrey Harris, an MD as well as a professor in MIT`s Department of Economics. Harris, who has long studied health issues, contends in a new issue of the journal Health Affairs that the private sector should be given significantly more incentives to help develop an HIV vaccine.
Read the whole article on Physorg
More from Physorg
Related
- Most would refuse emergency use H1N1 vaccine or additiveTue, 29 Sep 2009, 12:23:47 EDT
- Giving an additional early vaccination may reduce measles outbreaksFri, 25 Jul 2008, 5:56:28 EDT
- NIAID describes challenges, prospects for an HIV vaccineWed, 27 Aug 2008, 17:35:41 EDT
- National Vaccine Advisory Committee recommends increased adolescent immunizationMon, 7 Jul 2008, 10:36:00 EDT
- Results of landmark study of HIV vaccine published in the LancetWed, 12 Nov 2008, 18:42:45 EST